A bill to amend the Federal Food, Drug, and Cosmetic Act to authorize the use of investigational individualized medical treatments by patients diagnosed with a life-threatening disease or condition or severely debilitating illness, and for other purposes.
See how your representatives voted on this bill.
DeepSyte matches this bill to the issues you care about and shows whether your reps' votes line up — not party, not press releases. Take the 2-minute values quiz to see your alignment.
Alignment with your views
Sign in and take the values quiz to see how this bill lines up with what you've said.
Summary
Based on the bill's title, this legislation would amend the Federal Food, Drug, and Cosmetic Act to permit patients with life-threatening diseases or severely debilitating illnesses to access investigational individualized medical treatments. The bill appears to expand so-called 'right-to-try' provisions, allowing use of experimental therapies outside standard FDA approval pathways. The full text was not available for review.
Values analysis
Sign in and take the values quiz to get a personalized read on how this bill lines up with your positions.
How your representatives voted
Sign in to see how your representatives voted on this bill.